Cross-referencing clinical data
EarlyMyoviridae LL12
Myoviridae LL12.
The fourth bacteriophage strain in the PreforPro blend, targeting harmful gut bacteria. Expands the PreforPro blend's target range by going after a different set of harmful gut bacteria than the other three phages.
EarlyResearch strength15mgDaily amount
Reviewed March 2026
- Category
- General
- Also filed under
- Broadens bacterial targeting spectrum in PreforProSupports microbiome balancePart of studied phage cocktail
What Myoviridae LL12 is, and what it does.
- Does it work
- Important team player in a cocktail approach. Multi-phage blends are smarter than single-phage products. But the evidence for PreforPro overall is still early-stage, and LL12's individual contribution is unknown.
- How much to take
- 15 mg as part of the PreforPro blend. There's no way to dose LL12 individually, and no reason to try.
- The first dose
- Nothing perceptible. The phage is doing its microscopic work, but you won't notice.
- With regular use
- Weeks 3-4: potential mild improvements in digestive comfort as part of the full blend's effects.
- How well tolerated
- Well tolerated. Like all bacteriophages, LL12 can only infect specific bacteria. Human cells are completely off-limits.
- How it feels
- You can't feel individual phages. The blend as a whole may produce subtle improvements in gut comfort over time.
About 15mg a day is the studied dose.
How much to take a dayLimited data
15mg
The doseThe daily amount the trials actually used. A product at this figure is dosed right where the research is.
Above 15mgMore capsules, not more effect. Rarely in a serving anyway.
The proof, claim by claim.
These words describe the research, not the molecule's worth. Research strength is how much work stands behind one claim, and it is never a product score.
- Reduces harmful gut bacteria populations
- Multi-phage approach prevents resistance
PubMedCochraneClinicalTrials.govNIH ODSSUPP.AILabs test. IngredientMD verifies.PubMedCochraneClinicalTrials.govNIH ODSSUPP.AILabs test. IngredientMD verifies.
Questions people ask about Myoviridae LL12.
- Why do you need four phages instead of one?
- Each phage only targets specific bacteria. One phage alone is too narrow. Four phages cover more ground and make it harder for bacteria to develop resistance. It's like sending four different specialists instead of one.
- What happens if the phages run out of targets?
- They naturally decline. Phages can only replicate inside their target bacteria. No targets, no replication, phages get cleared. It's a beautifully self-regulating system.
- Can I take this with antibiotics?
- Yes, but there's a catch. Antibiotics might kill the bacteria that phages need to replicate. It won't harm you, but the phages become less effective during antibiotic treatment.
- Is this well tolerated in kids?
- Based on the mechanism, yes. Phages can't interact with human cells regardless of age. But PreforPro hasn't been specifically studied in children, so talk to your pediatrician.
- How is this different from a probiotic?
- Probiotics add good bacteria. Phages remove bad bacteria. They're complementary strategies. Taking both is actually smarter than either alone.
- Will I need to take this forever?
- Not necessarily. If your gut ecosystem stabilizes, you might not need ongoing supplementation. But if the harmful bacteria return (diet, stress, antibiotics), you might benefit from another round.
Nothing to show here, and the reason why.
A pairing appears on this page only when a trial gave both ingredients together and measured the result. Myoviridae LL12 has none that clears that bar.
No pairing for Myoviridae LL12 has cleared review yet.
Stitching two separate single-ingredient studies into a pairing is the one thing this engine will not do. When a study of the combination itself holds up at source, it lands here with its citation.
No invented synergy. Where actives were studied on their own rather than together, the record shows each on its own evidence, never a combined effect no trial measured.
Research strength. Research strength says how much work stands behind the combination. It is never a product score.
Independent record. Every finding is cited to a named trial, dated, and never written by the brand.
20 pairings are live across the library today. Checked 20 July 2026.
Plays well withEstablished knowledge, not a trial
No study gave these as a pair, so they are not in the card above. But the reason they belong together is settled biochemistry, not a guess, so it is worth knowing.
Myoviridae LL12 + probioticsEstablished microbiology: lytic phages infect specific bacterial hosts, so a phage preparation and a live bacterial supplement can be complementary or antagonistic depending on host range overlap.
Phage host specificity is settled microbiology and cuts both ways. A Myoviridae preparation aimed at gram-negative targets should not lyse a Lactobacillus or Bifidobacterium strain. Whether a given commercial phage overlaps a given probiotic strain is a product-level question the label has to answer.
Myoviridae LL12 + lactobacillus-plantarumHost-range biology: phages of the Myoviridae morphotype used in gut preparations are typically selected against Escherichia and related gram-negative hosts, not against lactobacilli.
The two occupy different sides of the same niche, one reducing a target population and one adding a resident. The complementarity depends entirely on the phage cocktail's declared host range. Read it as a formulation rationale, not a measured combination effect.
Myoviridae LL12 + bifidobacterium-longumBifidobacteria are gram-positive and outside the host range of phages selected against gram-negative enteric targets.
Host specificity is why a phage preparation and a bifidobacterial supplement are formulated together. The claim is about who the phage can infect, not about a measured shift in either population when both are taken.
Myoviridae LL12 + saccharomyces-boulardiiBacteriophages infect bacteria only; a yeast has no bacterial receptors and cannot be a phage host.
This is settled virology. A phage preparation cannot act on Saccharomyces boulardii in either direction. The pairing is mechanically independent, which is the whole point of combining them.
Myoviridae LL12 + inulinPrebiotic fibre is fermented by resident bacteria; a phage preparation acts on a target population. The two operate on different sides of the same community.
Inulin's fermentation by bifidobacteria is established. A phage cocktail selectively reduces a susceptible host population. Formulas combine subtraction and feeding, and the combined effect on community composition has not been measured in the sources available here.
Myoviridae LL12 + fos-fructooligosaccharidesShort-chain fructans are fermentable substrate for resident saccharolytic bacteria, a settled prebiotic mechanism.
The fibre feeds residents while the phage acts on a specific host. Neither depends on the other chemically. The rationale is community-level and unquantified here.
Myoviridae LL12 + resistant-starchResistant starch reaches the colon intact and is fermented to short-chain fatty acids, established nutritional biochemistry.
Fermentation substrate and phage lysis act on different levers of the same community. The combination is a formulation choice. No study of the pair is cited here.
Myoviridae LL12 + butyrateButyrate is the primary energy substrate of colonocytes, established physiology, and is unaffected by phage activity.
Supplying butyrate directly is nutritional support of the colonic epithelium. A phage preparation acts on bacteria and not on the host cell. The two are mechanically independent.
Myoviridae LL12 + betaine-hclEstablished pharmacology of gastric acid: low pH inactivates most bacteriophage virions, and an acidifying supplement lowers gastric pH further.
Phage capsids and tail structures lose infectivity under strong acid, which is why oral phage products use acid protection. A betaine hydrochloride supplement pushes gastric pH down. Taking the two at the same time works against the phage preparation's survival to the intestine.
Myoviridae LL12 + sodium-bicarbonateBicarbonate neutralises gastric acid, established chemistry, and acid neutralisation is the standard laboratory method for protecting orally delivered phages.
Raising gastric pH is the mechanism behind antacid co-administration in phage delivery work. Whether an over-the-counter bicarbonate dose does this reliably in a fed stomach is unstated here. Read it as a plausible delivery aid rather than a measured one.
Myoviridae LL12 + activated-charcoalActivated charcoal is a broad, high-surface-area adsorbent that binds particulate and macromolecular material, which is established physical chemistry.
A phage virion is a protein and nucleic acid particle, exactly the size class charcoal adsorbs. Co-administration would be expected to reduce the number of active virions reaching the colon. Separating the two by several hours is the conventional handling of any charcoal interaction.
Myoviridae LL12 + bentonite-clayBentonite is a layered aluminosilicate with high cation exchange capacity that adsorbs proteins and viral particles, established colloid chemistry.
Clay adsorbents bind virions non-specifically. Taking one with a phage preparation is expected to lower the delivered active count. This is mechanistic reasoning, not a measured loss.
Myoviridae LL12 + digestive-enzymesProteases degrade protein structures, and a phage capsid and tail are protein assemblies.
Supplemental protease exposure is a plausible route to capsid damage, though phage capsids are comparatively protease resistant and intestinal proteases are already present. The concern is mechanistic and unquantified. Separating doses is the cautious handling.
Myoviridae LL12 + l-glutamineGlutamine is the preferred fuel of enterocytes, established metabolic biochemistry, and acts on the host tissue rather than on the microbial community.
Nothing about glutamine metabolism touches phage infectivity or bacterial host receptors. The two sit in the same formula addressing different targets. Independence here is the useful fact.
Myoviridae LL12 + zinc-carnosineZinc carnosine is used for support of the normal gastric and intestinal lining and acts on host tissue, not on bacteriophage particles.
Host-directed and microbe-directed ingredients do not compete mechanically. The pairing is a formulation choice in gut-support blends. No combination measurement is cited here.
Myoviridae LL12 + colostrum-bovineBovine colostrum carries immunoglobulins that bind bacterial surface structures, an established immunological mechanism.
Immunoglobulin binding and phage adsorption both target bacterial surface molecules, so some receptor competition is conceivable. It has not been measured in the sources here. The direction of any net effect is unknown and should be stated as such.
Who should be cautious
Talk to a doctor before taking Myoviridae LL12 if any of these apply to you: Individual strain effects unknown, Part of a blend, not studied alone. These are flags to check first, not effects Myoviridae LL12 is known to cause.
Not medical advice. Show the label to your pharmacist.Getting Myoviridae LL12 from food.
The whole-food sources on file. A supplement closes the gap, it does not replace dinner.
Fermented foodsSoil contact (gardening)Unpasteurized dairy
A gram-for-gram figure (how much of each you would eat to match a dose) will appear here once it is sourced and reviewed. This page will not print a number it cannot cite.
The forms it comes in.
Freeze-dried phage preparationPhage lysate purified and freeze dried with a cryoprotectant carrier such as trehalose or maltodextrin.Fits Capsules, tablets and dry blends where shelf stability without refrigeration is required.Trade-off Active titre falls over shelf life and with heat exposure, so the number that matters is titre at expiry rather than at manufacture.
Buffered liquid suspensionPurified virions held in a buffered saline suspension at a stated plaque-forming unit count.Fits Liquid formats and applications where the dry-down step is undesirable.Trade-off Requires cold-chain handling and is exposed to gastric acid without an added protective step.
Delayed-release presentationLyophilised phage inside a polymer coating that stays intact at gastric pH and dissolves at higher intestinal pH.Fits Products aiming to deliver intact virions past the stomach.Trade-off Adds excipients and cost, and release depends on gut transit pH, which varies between people.Active and formulation aid
What the strongest studies found
The essence, in one line each.
- In a 4-week randomised, double-blind, placebo-controlled trial in 68 healthy adults, adding a bacteriophage blend containing LL12 to a Bifidobacterium animalis subsp. lactis probiotic showed a within-group improvement in a self-reported gut symptom score (p = 0.01) and a larger rise in Lactobacillus and short-chain fatty acid producing bacteria than the probiotic alone.Randomised trial. Grubb et al., 2020 (Nutrients). PMID 32824480 ↗
These are the studies our verdict leans on, chosen from the 8 we read for Myoviridae LL12. The full linked list is below.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.
